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PreviewsThe Laboratory in a Droplet
In this issue of Chemistry & Biology, the groups of
Tawfik [1] and Griffiths [2] present fluorescence-
activated cell sorting of double emulsions as a gener-
ally applicable screen for enzyme activity. This novel
methodology increases the throughput of a typical
enzyme screen by two orders of magnitude.
Numbers are all important in the world of high-through-
put protein technology, as the size of the throughput can
make the difference between success (striking gold with
a rare positive event) and failure (not digging deep
enough!). Today’s biological questions often concern
scales of millions and billions: the human interactome
is currently estimated at 280,000 functional interactions
from a total of 2.43 108 possible pairwise combinations,
whereas screening for tomorrow’s antibody pharma-
ceuticals is performed on libraries of 109–1013 molecules
(www.cambridgeantibody.com). Current techniques for
assaying enzyme activity, however, fall far short of the
mark. Typical high-throughput screens are performed
in microplates at scales of 103–105 reactions, and the
investment of handling time and reagent costs fixes
a ceiling of 106–107.
Microplates permit parallel reactions of soluble mole-
cules without diffusion, cross contamination, or loss of
identity of each well, but trends toward miniaturization
and increased throughput will eventually reach their lim-
its. Nature suggests an alternative compartmentaliza-
tion, namely the cell, which retains the advantages of
the microplate, but at drastically reduced size. Cells
keep together the genes, the RNAs, and the proteins
that they encode, and the products of their activities,
thus linking genotype to phenotype. Inspired by this
property, an in vitro system of cell-like compartments
was developed by Tawfik and Griffiths in 1998 [3]. An
aqueous in vitro transcription/translation reaction is
emulsified to give a water-in-oil (w/o) emulsion of 1010
droplets. Since DNA is added at limiting dilution, each
aqueous droplet contains a single gene, and acts as
a unique, independent reaction vessel. Initially the
method was demonstrated by in vitro expression of
DNA methyltransferases, which then methylated their
own genes, providing a selection criterion for active en-
zymes.
In the last few years, activity-based selections of other
DNA-associated enzymes have been developed, includ-
ing polymerases [4] and restriction enzymes [5]. Heat-
stable w/o emulsion formulations allow PCR in emulsion
as a method for superior unbiased amplification of com-
plex samples of genomic DNA or RNA [6], and the gen-
eration of libraries of DNA on beads as a viable alterna-
tive to cloning [7–9]. In vitro expression in emulsion is an
efficient method to generate large libraries of proteins
physically linked to their encoding genes either by direct
covalent attachment or via beads [10]. Microfluidic
channels offer improved methods to generate andmanipulate emulsions of precisely controlled droplet
size, and the contents of droplets can be interrogated
by confocal microscopy [11]. Recently the massively
parallel nature of emulsified reactions was exploited
by two independent groups to sequence an entire bac-
terial genome in a single reaction [12, 13]. Each group
developed an innovative method of sequencing by syn-
thesis, and in both cases, the role of the emulsion is in
single-molecule ‘‘cloning’’ and template preparation on
beads.
Emulsion technology offers unprecedented high
throughput of compartmentalized reactions and will un-
doubtedly be taken up, adapted, and applied for diverse
new methods, some as yet unimagined. Nevertheless, it
has suffered from one serious drawback so far: the lack
of a general method to assay the contents of each drop-
let and retrieve those of interest. Directed evolution of
enzyme function in emulsions was either obligately
linked to gene survival (selection rather than screening),
with the inherent compromises in scope of reaction and
dynamic range, or was reliant on bead capture and sub-
sequent screening of the beads.
To overcome this limitation, the groups of Tawfik and
Griffiths have turned back to the analogy of cells. Fluo-
rescence-activated cell sorting (FACS) is a cornerstone
technique in biology, as single cells can be selected at
a rate of 107 per hour on the basis of one (or several) fluo-
rescence properties. Fluorescence assays are extremely
sensitive, and the display of proteins on the surface of
yeast, followed by capture of fluorescent ligands, is be-
coming an important screen for binding affinity [14]. Al-
though fluorogenic substrates exist for many enzymes,
FACS has not been widely applied to screen enzyme ac-
tivity because of the difficulty in capturing the fluores-
cent products after the reaction. For individual enzymes,
particular strategies have been devised to capture prod-
ucts on the cell surface [15], or on beads [16], but the
need to design and synthesize a new substrate for
each enzyme severely limits the scope of FACS for appli-
cation to new enzymes, and limits the accessibility to
specialist laboratories.
The breakthrough described in this issue of Chem-
istry & Biology [1, 2] lies in the formation of double water-
in-oil-in-water (w/o/w) emulsions to provide stable link-
age between genes, enzymes, and enzyme products.
The oil layer which surrounds each droplet has low, con-
trollable permeability, allowing fully soluble reactions to
be performed in complete isolation from each other. The
external aqueous phase renders the emulsions nonvis-
cous and amenable to manipulation in a standard flow
sorter (Figure 1). These papers pave the way for FACS
screening of almost any fluorogenic assay. The two
groups demonstrate the efficiency of the method with
unrelated enzymes: Tawfik and coworkers assayed thi-
olactonase activity by coupling of the reaction product
to a thiol-reactive fluorogenic dye, whereas Griffiths
and coworkers detected b-galactosidase by the release
of fluorescein from fluorescein di-b-D-galactopyrano-
side. Test mixtures of active and inactive genes were
screened to demonstrate detection of enzyme activity,
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1256Figure 1. Water/Oil/Water Emulsion for Ge-
notype-Phenotype Linkage during Fluores-
cence-Activated Cell Sorting
Various methods for screening enzyme activ-
ity by FACS are shown in schematic form. Di-
rect screening of cells (lower right) or en-
zymes on beads (lower left) rely on physical
capture of the fluorophore, whereas the novel
emulsion-based methods presented in this
issue use soluble fluorophores. The in vitro
strategy of Griffiths and coworkers is shown
on the left: Each gene (of a library) is trans-
lated within its own droplet in a water/oil
emulsion. Active enzymes (blue balls) convert
substrate (gray squares) to product (yellow
stars), thus rendering their droplet fluores-
cent. By contrast, Tawfik and coworkers
transform and express the gene library in
E. coli (shown on the right). Single bacteria
are compartmentalized in the aqueous drop-
lets of a water/oil emulsion. The enzyme reac-
tion then takes place inside the emulsion, and
droplets containing active enzymes become
fluorescent. Finally the strategies converge
with a second emulsification to yield an exter-
nal aqueous phase for FACS separation of the
fluorescent and nonfluorescent droplets.enrichment of genes encoding active enzymes (by 300-
fold), and the ability to distinguish different rates of en-
zyme activity by the difference in fluorescence intensity.
Both groups chose an enzyme that had previously been
studied by directed evolution, thus safeguarding the
success of the experiment while proving the worth of
the system by evolving hundred-fold improvements on
the low activities of the parent proteins (PON1 [1] and
Ebg [2]). In each case, the improved mutants were equal
to the best mutants isolated by traditional methods of
bacterial colony screening on agar plates. Furthermore,
Griffiths and coworkers discovered new beneficial mu-
tations in the Ebg system, which was thought to have
been mutated to exhaustion.
An important difference between the two experiments
lies in the means of protein expression. Griffiths and
coworkers used in vitro translation, which combines
the advantages of cloning-free library preparation, lack
of bias due to clonal selection, control of the reaction
conditions and constituents, and the potential to work
with toxic substrates or toxic proteins [2]. Tawfik and
coworkers emulsified intact E. coli, expressing enzyme
variants either in the cytoplasm or on the cell surface,
to obtain higher enzyme concentrations [1]. It seems
likely that, for future applications, the choice between
a cell-based or in vitro approach will be dictated by
the activity in question, and that both approaches might
be used in turn during the evolution of a single enzyme,
perhaps taking advantage of the high enzyme concen-
trations in bacteria for the initial evolution of activity
against a new substrate and then using a cloning-free
and more chemically defined in vitro system for iterative
improvements to fine tune substrate selectivity. In vitro
display technologies such as bead display or ribosome
or mRNA display should also be compatible with wa-
ter/oil/water emulsions, and the technique might also
be adapted to screen ribozymes for multiple turnover.
The enormous battery of available fluorogenic sub-strates and coupled assays should allow flow sorting
of emulsions to be applied to achieve new goals with
many different biocatalysts.
Each double emulsion approach offers massively par-
allel, yet individual and identifiable, femtoliter reaction
compartments, combined with minimal handling time.
High-throughput enzyme screening is a limiting factor,
not just in directed evolution, but in other areas such
as enzyme discovery by function-based cloning, func-
tional genomics, and drug discovery. For selection of
enzymes to catalyze commercially valuable transforma-
tions, or for assays of small amounts of natural products
or drug leads, the small reaction volume (50 microlitres
of aqueous phase forms 1010 droplets), and high local
concentrations, may be particularly important. This
breakthrough increases the throughput of a typical en-
zyme screen by over two orders of magnitude, and ap-
plication to other biocatalysts promises to be simple.
Apart from a flow sorter, the process does not require
specialized equipment and could become as widely
adopted as microplate screening.
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Acyclic Peptide
Inhibitors of Amylases
In this issue of Chemistry & Biology, a library screen-
ing approach reveals a linear octapeptide inhibitor of
a-amylases reached by de novo design [1]. The se-
lected molecule shares characteristics with naturally
occurring protein inhibitors—a result that suggests
general rules for the design of peptide-based amylase
inhibitors may be achievable.
Amylase proteins, part of the broader class of hydrolytic
enzymes called glycosidases, cleave the glycosidic link-
ages of starch into disaccharide fragments that are sub-
sequently broken down into glucose (Figure 1). Inhibi-
tors of amylases have already demonstrated their
utility in aiding diabetics [2]. The glucose levels of dia-
betics can be controlled after meals by administration
of an amylase inhibitor such as acarbose. Acarbose is
a natural product obtained by fermentation and is struc-
turally related to the amylase oligosaccharide substrate,
as up to five glucose residues are known to be accom-
modated in the amylase active site [3].
Interestingly, some plants and microorganisms pro-
duce amylase inhibitors that are based on protein rather
than carbohydrate motifs. These inhibitory proteins,
which range in size from 32 amino acids with 3 disulfide
bonds to over 19 kDa, serve to regulate endogenous
amylase activity, for example in plant seeds, as well as
to defend against digestive amylases from other organ-
isms such as insects [4].
Although X-ray structures for five of the seven protein-
aceous inhibitor family members are known [5–9], the
complex nature of the interaction has made rational de-
sign of smaller versions of these inhibitors challenging.
Phage display methods have been used to produce al-
tered proteins to serve as amylase inhibitors [10, 11].
However, in the last decade, the use of peptides rather
than whole proteins to mimic carbohydrates has
emerged as a strategy for vaccine design as well as for
the design of glycosidase inhibitors [12]. Although meta-11. Dittrich, P.S., Jahnz, M., and Schwille, P. (2005). ChemBioChem
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bolic stability is an issue, smaller peptides usually are
easier to synthesize than carbohydrates and less likely
to be immunogenic than large proteins. Smaller peptides
are also more amenable to computational modeling to
correlate properties such as charge distribution with ac-
tivity [13]. The 74 amino acid protein Tendamistat has
only 15 amino acids that actually interact with amylase
and therefore has served as a good model for the rational
design of a variety of linear and cyclic peptide inhibitors
[13–16]. However, the discovery of unrelated peptides
has been a challenge. Unrelated peptides have the po-
tential for improved properties such as solubility, stabil-
ity, and selectivity.
In this issue of Chemistry & Biology, the Mares group
reports the generation of a random combinatorial pep-
tide library for the discovery of an octapeptide inhibitor
of the reaction catalyzed by porcine pancreatica-amylase
[1]. Structure/function relationship studies of the result-
ing octapeptide found that addition of a tosylate group
by chemical means to one arginine residue generated
an even tighter binding inhibitor (Figure 1). The new pep-
tide inhibits the porcine a-amylase more strongly than
the clinical drug acarbose. Interestingly, the modified
octapeptide appears to use some of the same binding
motifs as the natural protein-based inhibitors, namely
aromatic and arginine moieties, but arranges these
motifs in a simple linear scaffold. In fact, the flexibility
of the linear scaffold is crucial for effective binding, as
the cyclic version of the same peptide is completely
inactive [1].
Selectivity among varies glycosidase families [17] is
the next issue that has to be addressed in the dis-
covery of inhibitors. Although other a-amylases and
a-glucosidases are also inhibited by the octapeptide,
the new compound does appear to be selective for gly-
cosidases found in family 13. No evidence for inhibition
of enzymes from seven other families was seen. There-
fore, the octapeptide likely will inhibit amylases without
fear of also shutting down other structurally unrelated
glycosidases with important cellular functions.
The work by Mares and coworkers is an important first
step in the de novo design of amylase inhibitors, but
